Comparison of Prophylactic Carbetocin and Oxytocin in the prevention of Postpartum hemorrhage during Elective Caesarean section by Randomised controlled trial

Prophylactic Carbetocin versus Oxytocin in the prevention of Postpartum hemorrhage during Elective Caesarean section by Randomised controlled trials - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054499

Enrollment

Registered

2023-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

Intervention1: CARBETOCIN 100 MCG intravenous: INJ CARBETOCIN 100MCG IN 100 ML NS INTRAVENOUS after delivery of anterior shoulder Control Intervention1: Inj OXYTOCIN 10 units intravenous: INJ OXYTOCIN

Eligibility

Inclusion criteria

Inclusion criteria: ALL PREGNANT WOMEN WITH OR WITHOUT PREDISPOSING FACTORS FOR POST PARTUM HEMORRHAGE

Exclusion criteria

Exclusion criteria: UNCONTROLLED HYPERTENSION SEVERE PREECLAMPSIA RENAL DISEASE CARDIAC DISEASE LIVER DISEASE ASTHMA

Design outcomes

Primary

Measure	Time frame
TO MEASURE INTRAOPERATIVE AND POSTPARTUM BLOOD LOSS IN PATIENTS RECEIVING CARBETOCIN AND OXYTOCINTimepoint: IN MILLI LITRES IN FIRST 24 HOURS OF DELIVERY	—

Secondary

Measure	Time frame
ADVERSE DRUG REACTION OF CARBETOCIN AND OXYTOCIN NEED FOR ADDITIONAL UTEROTONIC AGENTS NEED OF BLOOD AND BLOOD PRODUCTS TRANSFUSIONTimepoint: IN FIRST 24 HOURS AFTER DELIVERY	—

Countries

India

Contacts

Public ContactBulasara Yogita

Bharati Vidyapeeth deemed to be University medical College

vaishutaralekar@gmail.com7989962094

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026